FDA OKs Given's colon camera pill


The FDA has approved Given Imaging's (GIVN) PillCam Colon camera-in-a-pill, which can be used for detecting colon polyps in patients after an incomplete optical colonoscopy.

A colon polyp is a growth on the surface of the colon.

In the U.S., 750,000 patients a year experience an incomplete colonoscopy, and the total global market for Given's device is 3M procedures a year.

Given is in the process of being acquired by Covidien (COV) for $860M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs